Toficalm
Toficalm

1.78
A clinical formulation indicated for Mental Health. This intervention supports a balanced state of calm by addressing symptoms related to anxiety and emotional tension.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Tofisopam
Reference Brand
Tofisopam
Product Origin
Generic Brand
Product Manufacturer
Macleods Pharmaceuticals
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Mental Health, Anxiety Relief
Product Category
Anxiolytic
Pharmacological Class
2,3-benzodiazepine
Manufacturer Description
An atypical anxiolytic designed to alleviate symptoms of anxiety and tension without causing significant sedation to support mental calmness.
Mechanism of Action
Unlike standard benzodiazepines, it binds to different sites in the brain. It relieves anxiety without muscle-relaxant or significant sedative effects, preserving cognitive and motor functions.
Route of Administration
Oral
Onset Time
Within 1 hour
Duration
6–8 hours
Contraindications
Respiratory failure, Sleep apnea, Severe liver or kidney disease, Pregnancy
Severe Adverse Events
Seizures (in predisposed patients), Severe allergic reactions, Confusion, Respiratory depression
Common Side Effects
Nausea, Headache, Dry mouth, Itching
Uncommon Side Effects
Sleep disturbances, Constipation, Irritability, Loss of appetite
Drug Interactions
Alcohol, Benzodiazepines, Antipsychotics, Opioids
Pregnancy Safety Warnings
Contraindicated in the first trimester; not recommended during breastfeeding.
Age Restrictions
Not recommended for children.
Storage Guidelines
Store at room temperature.
Related Products
Buspirone, Alprazolam, Etizolam
Information for Toficalm is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories